|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Long-term prepaid insurance | ||||||
| Investments held in Trust Account | ||||||
| Deferred offering costs | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||
| Current liabilities | ||||||
| Accrued expenses | ||||||
| Advance from Sponsor for Private Placement Units | ||||||
| Promissory note - related party | ||||||
| Accrued offering costs | ||||||
| Total current liabilities | ||||||
| Advisory fee payable | ||||||
| Deferred underwriting fee payable | ||||||
| TOTAL LIABILITIES | ||||||
| COMMON STOCK SUBJECT TO REDEMPTION (Note 2) | ||||||
| Class A ordinary shares subject to possible redemption, 27,600,000 shares outstanding at a redemption value of $10.55 and $10.36 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||
| SHAREHOLDERS’ DEFICIT | ||||||
| Ordinary share, value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| TOTAL SHAREHOLDERS’ DEFICIT | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
